CorConsult Rx: Evidence-Based Medicine and Pharmacy
CorConsult Rx: Evidence-Based Medicine and Pharmacy
Mike Corvino, PharmD, BCPS, BCACP, CDCES and Cole Swanson, PharmD, CDCES
Exxua (gepirone): the newly approved antidepressant
22 minutes Posted Oct 25, 2023 at 1:47 am.
Download MP3
Show notes

On this episode, we discuss the 5-HT1A receptor agonist, Exxua (gepirone). Exxua was recently FDA approved for the treatment of general depression. We review the long road this medication took to get approved. We also summarize the dosing, adverse effects, drug-drug interactions, etc for Exxua. 

Thanks for listening!

We want to give a big thanks to our sponsor, High-Powered Medicine. HPM is a book/website database of summaries for over 150 landmark clinical trials. You can get a copy of HPM, written by Dr. Alex Poppen, PharmD, at the links below: 

Purchase a subscription or PDF copy -

Purchase the paperback and hardcover - Barnes and Noble website

We want to give a big thanks to our main sponsor Pyrls. Try out their drug information app today. Visit the website below for a free trial:

If you want to support the podcast, check out our Patreon account. Subscribers will have access to all previous and new pharmacotherapy lectures as well as downloadable PowerPoint slides for each lecture. You can find our account at the website below:

If you have any questions for Cole or me, reach out to us on any of the following:

Text - 415-943-6116

Instagram and other social media platforms - @corconsultrx 

This podcast reviews current evidence-based medicine and pharmacy treatment options. This podcast is intended to be used for educational purposes only and is intended for healthcare professionals and students. This podcast is not for patients and not intended as advice or treatment.